Brian Low Financial Group
VRTX icon

Brian Low Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Brian Low Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$288K Buy
551
+9
+2% +$4.61K 0.16% 86
2026
Q2 		$269K Buy
542
+6
+1% +$2.66K 0.16% 96
2026
Q1 		$239K Buy
536
+13
+2% +$6.06K 0.16% 103
2025
Q4 		$237K Buy
+523
New +$225K 0.17% 104

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Brian Low Financial Group's VRTX Position: Q3 2026 in Review

Brian Low Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 1.7% in Q3 2026, buying an estimated $4.61K and bringing the position to 551 shares worth $288K. The position accounts for 0.16% of the portfolio, ranked #86.

Brian Low Financial Group first reported a position in VRTX in Q4 2025 and has held it in 4 quarters since. 1,161 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Brian Low Financial Group held 551 shares of Vertex Pharmaceuticals worth $288K as of Q3 2026.
  • Brian Low Financial Group bought 9 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.61K.
  • Vertex Pharmaceuticals made up 0.16% of Brian Low Financial Group's portfolio in Q3 2026, its #86 holding.
  • Brian Low Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 1,161 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Brian Low Financial Group's 13F filing for Q3 2026, filed 28 Oct 2026.